STUDresearch · Non-peptide

Apigenin

Also known as

4',5,7-trihydroxyflavone · CD38 discussion flavonoid · Apigenin flavonoid · Chamomile flavonoid (dietary context) · 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one · Huberman sleep-stack apigenin (community shorthand) · Apigenine (common misspelling/EU labeling) · C15H10O5 flavone

Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.

Open in the directory ↗
Non-peptide Niche talk Systemic Oral Longevity & cellular energy

Systemic — oral plant flavone discussed in calm, sleep and NAD/CD38 stacks; not a local injectate or topical research peptide.

Tap a line to jump into the full notes. Research only — may be wrong.

Timing context & sources

Half-life in the body

A reliable human capsule half-life is not established in the sources reviewed.

A small human study examined capsule contents, but did not calculate a half-life. The often-repeated 91.8-hour figure concerns rat blood radioactivity, not free apigenin in people.

Borges sampled plasma at 0, 2, 4 and 6 hours: parent/metabolites were undetected in the isolated arm, while urinary conjugates were found. Non-detection is not proof of zero absorption or immediate clearance. Rat radioactivity and human sleep duration are different endpoints.

  • Apigenin: human capsule and food-matrix study (opens in a new tab)Borges et al. 2022, sections 2.2–2.3 and 3.3.1, Table 3, pp.91–92. Full original PDF/table reviewed.Three men received capsule contents dispersed in hot water; separate food-matrix arms differ. No elimination half-life calculated; sparse sampling cannot settle every formulation.
  • Apigenin: rat radiolabel experiment (opens in a new tab)Gradolatto et al. original abstract, blood-radioactivity kinetics after oral radiolabeled apigenin; reviewed via Europe PMC core API.Abstract only. The 91.8-hour endpoint is rat radioactivity, not human free-parent or felt-effect duration.

Felt duration people report

One poster describes sleep help for only a couple of days; others report calm or barely any effect. Another reports disturbed sleep and anxiety still present three days after stopping.

These are different personal experiences, not a typical duration. A report of fewer night wakings also included magnesium; no single ingredient can take all the credit.

Unverified preparations, varied amounts, age and other supplements confound. Forum cortisol/estrogen theories are not treated as measured causes; persistence of symptoms does not measure clearance.

  • Apigenin: sleep, calm and mixed experiences (opens in a new tab)Thread begun March 2023: deleted comment It helped me get to sleep; Symthisis; Alternative_Start_83; yogur23; BBMcFarland's three-days-after-stopping and age-69 replies.Self-reports with variable products and stacks, not prevalence or cause. Cortisol/estrogen guesses and unrelated melatonin timings are not adopted.

What people say 14

  • CD38 / NAD salvage: Top longevity-forum reason — “close the NAD drain” while precursors fill the tub; cell/animal CD38 data strong, human NAD after isolate oral not established. forum
  • Calm / wind-down: Users report easier evening downshift on capsules; often confounded by mag/theanine/chamomile ritual in the same stack. forum
  • Sleep onset / continuity: Anecdotal easier onset or fewer wakings at ~25–50 mg (sometimes 100–150 mg) evening; controlled primary-insomnia trial of chamomile extract (~540 mg extract) was largely null/trend-only on primary sleep metrics and daytime function. anecdote
  • Stack halo: Many wins credited inside mag + theanine + NMN combos — single-agent attribution weak. forum
  • Vs other flavones: Positioned as calmer/sleep-leaning cousin to quercetin/luteolin; less “senolytic pulse” culture than fisetin or dasatinib+quercetin. forum
  • Aromatase / hormone lore: Theoretical aromatase and 17β-HSD inhibition (Examine/in-vitro IC50 talk for aromatase ~low µM) appears in bro threads as mild estrogen-pathway interest — human endocrine outcome data at capsule doses unsettled; Huberman has publicly flagged estrogen-inhibition caution. forum
  • Anxiety (chamomile pathway): Chamomile-extract GAD trials used ~220–1100 mg stepped or ~1500 mg/day as 500 mg TID, with reported anxiety/mood improvements. At 1500 mg, the stated 1–1.2% range is 15–18 mg, not low teens; standardization may describe glycosides rather than free aglycone. Extract is not interchangeable with 50 mg pure-apigenin capsules. trial
  • Senomorphic (not classic senolytic): Compound-library screens and follow-on work frame apigenin as SASP-quieting / senomorphic rather than mass senescent-cell clearance like fisetin pulse culture or D+Q — marketing sometimes blurs this. lab
  • In-vitro oncology / enzyme modulation: Large antiproliferative, pathway, and alternative-splicing literature fuels “healthy aging” talk; human oncology intervention data for oral isolate incomplete. lab
  • Metabolic / cardiometabolic animal signals: Escande obese-mouse CD38 work; oral apigenin models for cardiac injury (~50 mg/kg class), HFD nephropathy, atherosclerosis/NAFLD parameters — mechanism interest, not human protocols. animal
  • Neuro / learning-memory (rodent): Oral and i.p. models report sedative/locomotor reduction, Bdnf/Creb-related signals, and cognitive protection in amnesia or aging contexts — not human cognition trials of isolate. animal
  • Muscle mass / function lore: Standalone mouse papers and N+A combo coverage get shared as “apigenin + training” curiosity; not a validated hypertrophy protocol in humans. animal
  • NMN + apigenin additive framing (N+A): Aged-mouse work (e.g. Aging Cell / lifespan-media coverage of oral N+A) is cited for multi-tissue regeneration, cartilage/bone/muscle preservation, and physical capacity better than either alone — still animal. animal
  • Anti-inflammatory / NLRP3 talk: Preclinical cytokine, oxidative-stress, and inflammasome papers (including high-fat / atherosclerosis mouse models) drive wellness framing. animal

Doses people talk about 22

  • Most repeated consumer anchor: ~50 mg oral once daily (usually evening) — default capsule size and Huberman sleep-stack figure across podcast notes and stack blogs. forum
  • Higher community band: Reddit/nootropics threads commonly discuss 100–200 mg (sometimes 150 mg as 3 × 50 mg); Nootropics Depot–style 200 mg SKUs spark “is 200 mg too much?” debates relative to the 50 mg Huberman default. forum
  • Upper fringe talk: Longevity protocol pages and some researchers mention 100–500 mg discussion ranges; human isolate outcome/safety tables at the high end are thin — not a clinical standard. forum
  • Huberman-style sleep stack ratios (widely copied, variants exist): Apigenin ~50 mg + magnesium L-threonate often cited ~140–145 mg (product/elemental wording varies by brand) or bisglycinate alternatives commonly discussed ~200–400 mg product magnesium + L-theanine ~100–400 mg (many land ~200–300 mg), taken ~30–60 minutes before bed. forum
  • CD38 / NAD companion dosing talk: Longevity blogs and stack notes often list apigenin ~50–100 mg daily beside NMN or NR (NMN/NR often discussed in hundreds of mg to gram-class ranges depending on protocol — not a locked clinical ratio to apigenin mg). forum
  • Facebook / longevity-formula shorthand example: “NMN or NR 250–500 mg + apigenin 50–100 mg” appears as a common complementary fill-and-spare drain pair in public longevity posts — still discussion, not a trial arm. forum
  • Lower oral animal anchor: Ogura-type oral rodent CD38/kidney work (~20 mg/kg oral) and other oral mouse models (e.g. ~5–50 mg/kg class across cardiac/metabolic papers) are still above typical 50 mg human capsules when naively scaled — used to argue “capsule may be under-dosed for NAD” vs “bioavailability unknown so stop guessing.” forum
  • Timing — sleep users: Full evening dose ~30–60 min pre-bed is the dominant schedule; some stack copies prefer not-full stomach (Huberman-adjacent notes mention avoiding a meal within the last ~3 hours). forum
  • Timing — NAD-first users: Some take morning with NMN/NR, others keep evening only for dual sleep+longevity convenience — no consensus PK-PD rule for CD38 coverage. forum
  • With fat / food: Small fat snack or meal sometimes used aiming better flavonoid absorption; SNEDDS/self-emulsifying research shows multi-fold relative BA gains in rats — not a validated clinical rule for plain isolate capsules. forum
  • Split vs single dose: Once-daily dominates; split AM/PM is uncommon because shortish free-parent half-life talk is still paired with once-nightly habit culture and conjugate/tissue stories that blur multi-dose logic. forum
  • Formulation premiums: Micronized, phytosome, liposomal, SNEDDS/self-emulsifying, or “enhanced absorption” SKUs priced higher; rat SNEDDS work reported ~3.3–3.8× relative oral bioavailability vs coarse powder — head-to-head free-plasma proof in consumers remains scarce. forum
  • Sleep-oriented band: Often ~25–50 mg evening; some protocols start low (~25 mg) then step to 50 mg if wind-down is the goal. forum
  • Common broader daily totals: Frequently 50–100 mg/day oral; many multi-capsule products label 100 mg as a serving (2 × 50 mg). forum
  • Sleep stack optional add-ons (same night culture): Myo-inositol ~900 mg some nights (Huberman “as needed” / every few nights framing in notes); glycine ~2 g; occasional commercial melatonin in multi-ingredient formulas — confounding rises fast. forum
  • Dietary baseline: Typical diet estimates often ~0.45–5 mg/day apigenin (some summaries extend lower bands ~0.45–1.17 mg); plant-heavy diets sometimes guessed higher (~tens of mg in extreme produce patterns) — still usually far below isolate capsules. trial
  • Chamomile extract trial context: Human anxiety/sleep studies discussed hundreds of milligrams to ~1500 mg/day extract near ~0.8–1.2% standardization. At 1500 mg that calculates to 12–18 mg, not low teens. Product-specific standardization may describe glycosides rather than free aglycone; extract amounts are not interchangeable with 50 mg pure capsules. trial
  • Primary insomnia extract note: ~540 mg chamomile extract (often split dosing in protocols) trended on daytime function without clear primary sleep win — used by skeptics of pure-isolate sleep claims. trial
  • Framing: All figures below are community/label/literature discussion for research education — not instructions for use. forum
  • Animal-to-human dose caveats (bro debate): Escande-style CD38 mouse work used high exposure (classic paper: ~100 mg/kg i.p. for a week in obese mice); naive allometric “human equivalent” chatter sometimes quotes hundreds of mg oral — heavily debated because route (i.p. vs oral), first-pass, conjugation, and toxicity differ. animal
  • Food matrix examples: Parsley-leaf human ADME work (e.g. large parsley meals / ~weeks of parsley providing tens of mg apigenin-equivalent mainly as glycosides) is not equivalent mg-for-mg to isolate labels; one cited parsley meal series reported mean serum apigenin ~127 nM peaking around ~7 h. trial
  • Uncertainty: No widely cited published human PK series for 50 mg isolated oral apigenin measuring free parent, conjugates, and NAD change in the same design — labeled mg is a weak proxy for exposure. trial

How it may feel 8

  • Night 1 / first doses: Mild calm, slightly easier wind-down, muscle-relaxant softness, or nothing obvious; not a knockout sedative for most at 50 mg. forum
  • Days 1–3: GI uncommon at modest capsule counts; sedation edge more noticeable if stacked with alcohol, RX GABAergics, large theanine, or glycine same night. forum
  • Nights 1–2 weeks: Typical sleep-log checkpoint — onset latency, night wakings, dream intensity, next-day grogginess — reassess timing (often 30–60 min pre-bed; some Huberman-adjacent notes say avoid large meal within ~3 h) before chasing higher mg. forum
  • Weeks 2–4: Subjective feel stays quiet vs stimulants or RX sedatives; many keep or drop based on sleep diary and morning clarity, not dramatic “on” sensation. forum
  • Months 1–3 (longevity users): Judged by energy/recovery, training, optional labs inside an NMN/NR stack — highly confounded by lifestyle and co-supps; CD38/NAD pathway is not a night-to-night “buzz.” forum
  • No clear change by ~3–4 weeks: Forums often question formulation (plain vs liposomal/phytosome/SNEDDS-style), fat co-ingestion, expectation mismatch (expecting benzos-level sedation or measurable NAD “rush”), not automatic double-dosing. forum
  • Dose-step experiences: Some users stay flat at 50 mg and report more calm or next-day fog only after moving to 100–200 mg; others report null at all common capsule totals. anecdote
  • Subgroups: Sleep-first logs use nightly subjective scores; CD38/NAD-first logs rarely “feel” pathway night-to-night and track longer horizons or bloodwork proxies. forum

Cycles people discuss 8

  • Daily habit culture: Open-ended nightly or daily capsules for weeks to months — no classic on/off peptide-style cycle. forum
  • Sleep trial blocks: Many self-experiment 2–8 weeks evening-only, then keep, drop, or adjust co-stack (mag/theanine/inositol). forum
  • With NAD precursor stacks: Usually continuous beside NMN/NR, not pulsed like high-dose fisetin “senolytic weekends.” forum
  • Vs senolytic pulsing: When bundled in multi-flavonoid “senolytic” products, marketing may imply intermittent use, but pure apigenin sleep/NAD users more often stay daily because the claimed mechanisms (CD38, GABA calm) are framed as chronic/pathway. forum
  • Time off: Some pause after ~1 month if sleep/energy claims don’t land; long-term pure-isolate safety tables in healthy humans remain limited. forum
  • Seasonal re-runs: Common during high-stress, travel, or poor-sleep seasons; no fixed lifelong cadence. forum
  • Tolerance talk: Dependence lore is low vs benzos; some still cycle off periodically to reassess baseline sleep without stack. forum
  • HRT / special-population pauses: Older caution notes (e.g. MU/progestin-context commentary advising against pure apigenin add-on to certain hormone therapies until more data) lead some users to avoid continuous isolate rather than cycle it — clinician-first territory. forum

Timing 12

  • Steady-state lore: Some reviews’ ~12 hour talk extrapolates from short free-parent half-lives, largely preclinical; it does not establish human steady state after nightly capsules. Conjugates, enterohepatic recycling and tissue binding further complicate coverage claims. forum
  • Why once-daily persists: Nightly calm goals and habit convenience recur in discussion. Short–moderate free-plasma coverage is a repeated rationale, not established human capsule kinetics or proof that more doses are needed. forum
  • Evening vs pathway timing: An hours-post-dose calm window appears in existing notes as timing talk, not a measured or typical duration. CD38/NAD-sparing stories remain chronic/pathway claims, not a dose-to-dose NAD rush. forum
  • Downstream claims: NAD-sparing, SASP quieting, metabolic markers lag Cmax in animal papers — mechanism talk, not proven human PK-PD at 50 mg. anecdote
  • Formulation impact: Liposomal/micronized/SNEDDS claims aim higher exposure (multi-fold relative BA in rat SNEDDS); community debates cost vs plain bulk powder without independent consumer plasma data. forum
  • Rodent free-parent PK band (common review summary): Oral Tmax often ~0.5–2.5 h; elimination half-life commonly cited ~1.8–4.2 h (review averages near ~2.5 h) — species, formulation, and assay (free vs total) dependent. animal
  • Bioavailability figures: Oral bioavailability sometimes cited near ~30% from rodent oral/IV AUC comparisons; human free-parent bioavailability for isolate capsules remains poorly characterized. animal
  • Gradolatto radiolabel / long half-life narrative: Classic rat oral radiolabeled work reported a long blood elimination half-time (~91.8 h), delayed appearance of radioactivity, and residual body radioactivity days later — often cited as “slow accumulation” lore; this tracks total radioactivity/metabolites differently from short free-aglycone half-lives in other studies. animal
  • Human food-matrix ADME: Studies of tea/parsley-style intake report free apigenin barely in circulation relative to conjugates; urinary excretion half-life in parsley-intervention work estimated around ~12 h in one review summary; recovery as urinary metabolites is a small fraction of intake in several citations. trial
  • Conjugation reality: Heavy intestinal/hepatic glucuronidation and sulfation (UGT/SULT); phase I CYP1A2 (and lesser CYP3A4/2B) can generate luteolin; free parent under-represents total exposure. trial
  • BBB talk: Rodent distribution work suggests brain presence under some routes; oral human brain levels at supplement doses unproven. animal
  • Microbiome / colon story: Large unabsorbed fraction reaches colon and is metabolized by microbiota into smaller phenolics that may re-enter circulation — some reviews argue metabolites contribute to net effects, not only parent aglycone. trial

More on what it is 8

  • Mechanism talk (simplified): Community compresses several stories: GABA-A / calm wind-down, CD38 NADase inhibition raising NAD pool, NLRP3/anti-inflammatory quieting, and senomorphic SASP modulation — often oversimplified into “sleep + NAD pill.” forum
  • Research lens: Treat NAD-sparing and sleep-mg claims as discussion until matched to isolate human endpoints; food/tea/chamomile extract ≠ capsule isolate dose-for-dose. forum
  • What it is: Plant flavone (4',5,7-trihydroxyflavone, C15H10O5) concentrated in chamomile, parsley, celery, oregano, thyme, and related foods; sold as oral isolate capsules/powders, not an FDA-approved drug. trial
  • Why people search it: Two dominant hooks — (1) Huberman-style nightly sleep stack (~50 mg apigenin + mag + theanine) and (2) CD38-inhibitor framing that may spare NAD+ next to NMN/NR (“fill the tub and slow the drain”). forum
  • CD38 / NAD story: Escande et al. (2013, Diabetes) showed apigenin inhibits CD38, raises intracellular NAD+, and in obese mice i.p. ~100 mg/kg for a week improved glucose/lipid markers; Ogura et al. (2020) used oral ~20 mg/kg in diabetic rats for kidney/CD38/SIRT3 work. Human isolate oral NAD endpoints largely missing. animal
  • Sleep / calm story: Strongest human data is chamomile extract (matrix often ~0.8–1.2% apigenin by mass), not pure 50 mg isolate; pure-isolate hypnotic RCTs are sparse. Dietary apigenin intake has correlated with sleep quality in observational work. trial
  • Evidence honesty: Decades of cell/animal work (inflammation, metabolism, oncology, neuro, senescence models); human oral isolate PK and outcome trials lag the marketing and podcast culture. trial
  • Bioavailability reality: Poor aqueous solubility (BCS class II talk), heavy first-pass glucuronidation/sulfation, low free plasma parent — labeled mg ≠ free circulating aglycone. Reviews often cite ~30% oral bioavailability from rodent oral/IV AUC math; conjugates dominate what is measured. trial

Stacks 10

  • Huberman sleep stack (highest copy-rate): Apigenin ~50 mg + magnesium L-threonate (often cited ~140–145 mg product wording) or bisglycinate variants (~200–400 mg product discussion) + L-theanine ~100–400 mg, ~30–60 min pre-bed. forum
  • Sleep stack add-ons: Glycine (~2 g discussion), myo-inositol (~900 mg some nights), occasional melatonin or commercial multi-ingredient sleep formulas — confounding rises fast. forum
  • What people avoid stacking carelessly same evening: Alcohol, RX sedatives/benzos/Z-drugs, and other strong CNS depressants — additive fog/sedation reports. forum
  • CD38 flavonoid compare-stack: Apigenin ~50–100 mg (sleep-leaning) vs quercetin higher hundreds-of-mg culture vs luteolin ~50–100 mg talk — overlapping CD38/inflammatory targets, different dose cultures and side-effect profiles. forum
  • Polyphenol bundle: Quercetin, luteolin, and/or fisetin together with apigenin — multi-agent confounding high; fisetin often pulsed as “senolytic,” apigenin often daily as sleep/NAD companion. forum
  • Longevity adjacency: Resveratrol, Ca-AKG, spermidine, or other healthspan staples appear nearby on shelves; mechanistic overlap is marketing-heavy. forum
  • Lifestyle co-factors: Fixed sleep schedule, morning light, alcohol cutback, caffeine timing (e.g. no late caffeine), and temperature/darkness often credited as much as the capsule for calm wins. forum
  • Theanine caveats inside the stack: Huberman-adjacent notes warn some people with sleepwalking/night terrors may worsen vivid/dream phenomena on theanine — users sometimes drop theanine and keep apigenin+mag. forum
  • NAD stack (CD38-sparing framing): Apigenin + NMN or NR (± plain niacin in older protocols) — complementary “fill + slow drain” story; common public shorthand pairs NMN/NR hundreds-of-mg bands with apigenin 50–100 mg. forum
  • NMN + apigenin (N+A) animal echo: Community cites additive aged-mouse regeneration/capacity papers when justifying co-admin — not a human protocol trial. animal

Storage notes 2

  • No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
  • Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum

Watch for 14

  • Sedation / next-day fog: Too much calm, muscle-relaxant feel, or grogginess — dose- and stack-dependent; worse with alcohol or other sedatives. forum
  • Not “food-level” risk by default: Concentrated daily isolate (e.g. 50 mg+) is not the same exposure as parsley garnish or a cup of tea. forum
  • GI: Occasional nausea, stomach discomfort, or loose stool at higher oral totals or empty-stomach multi-capsule loads. forum
  • Named interaction themes in consumer writeups: Cyclosporine, warfarin/anticoagulants, and some chemotherapy agents appear in secondary summaries as higher-concern co-use topics — still not a substitute for individualized medical review. forum
  • Hormone / endocrine talk: Phytoestrogen and aromatase-inhibition threads cut both ways in forums (some hope mild T:E tilt; others worry about estrogen suppression); Huberman has flagged estrogen-inhibitor caution especially for people wanting to maintain estrogen. Relevance at common capsule doses remains unsettled — not a proven T-booster. forum
  • HRT / menopausal / progestin context lore: Older university commentary advised against pure apigenin supplementation alongside certain progestin-containing hormone therapies until metabolism/interaction data clarified — sparse, not a substitute for medical advice. forum
  • Pregnancy / lactation / pediatric: Avoid or clinician-first; high-dose isolate safety tables sparse. forum
  • Source quality: Gray-market powders and weak COAs risk mislabel, heavy metals, or under-dosed flavone — third-party testing is a recurring buyer theme. forum
  • Allergy: Asteraceae (chamomile family) sensitivity can matter more for tea/extract than pure synthetic-path isolate, but product contamination/matrix varies. forum
  • Expectation harm: Null personal sleep response is common; chasing higher mg without addressing sleep hygiene is a frequent forum failure mode. anecdote
  • Antiplatelet / bleeding lore (mild): Some secondary sources mention mild antiplatelet properties as a theoretical co-use caution with blood thinners — human clinical magnitude at 50 mg unclear. forum
  • Drug interaction caution (CYP / transporters): Literature discusses CYP modulation (including CYP3A4-related inhibition signals among flavonoids) and transporter effects; animal work (e.g. apigenin pretreatment altering dasatinib PK via CYP3A2/P-gp/BCRP pathways) is used as a cautionary parallel — prescription co-use is clinician-first, not DIY stacking. animal
  • High-dose animal toxicity contrast: Some i.p. mouse work and acute high-exposure designs reported organ-stress signals at very high mg/kg bands while lower oral bands looked cleaner — another reason naive allometric megadoses are debated. Rat SNEDDS acute oral work has reported high LD50 estimates (e.g. >2000 mg/kg class in one OECD-style design) — does not prove chronic human megadose safety. animal
  • Research-only framing: Not established as a disease treatment; cancer-selectivity, AD-mouse, and kidney-protection stories are preclinical interest, not clinical protocols. trial

Updated: 2026-08-12

Evidence mix Mostly community / anecdote tags Full: every bullet (trial + community). Use Scan for a faster bro-science read.

All STUDresearch topics →